160 related articles for article (PubMed ID: 37019124)
1. Role of 68 Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies : A Prospective Pilot Study.
Rajaraman V; Meenakshi LA; Selvaraj AJ; Pottakkat B; Halanaik D
Clin Nucl Med; 2023 Jun; 48(6):e281-e288. PubMed ID: 37019124
[TBL] [Abstract][Full Text] [Related]
2. Comparison of PET imaging of activated fibroblasts and
Shi X; Xing H; Yang X; Li F; Yao S; Congwei J; Zhao H; Hacker M; Huo L; Li X
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1593-1603. PubMed ID: 33097975
[TBL] [Abstract][Full Text] [Related]
3. Clinical prospective study of Gallium 68 (
Jinghua L; Kui X; Deliang G; Bo L; Qian Z; Haitao W; Yaqun J; Dongde W; Xigang X; Ping J; Shengli T; Zhiyong Y; Yueming H; Zhonglin Z; Yong H; Yufeng Y
Eur J Nucl Med Mol Imaging; 2023 Jun; 50(7):2152-2166. PubMed ID: 36809426
[TBL] [Abstract][Full Text] [Related]
4. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
[TBL] [Abstract][Full Text] [Related]
5. 68 Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma : Comparison With 18 F-FDG PET/CT and Abdominal 68 Ga-FAPI-04 PET/MR.
Zhang Z; Cheng C; Jiang H; Pan G; Yu Y; Jin G; Zuo C
Clin Nucl Med; 2024 May; 49(5):409-418. PubMed ID: 38465929
[TBL] [Abstract][Full Text] [Related]
6. Superior Tumor Detection for
Pabst KM; Trajkovic-Arsic M; Cheung PFY; Ballke S; Steiger K; Bartel T; Schaarschmidt BM; Milosevic A; Seifert R; Nader M; Kessler L; Siveke JT; Lueckerath K; Kasper S; Herrmann K; Hirmas N; Schmidt HH; Hamacher R; Fendler WP
J Nucl Med; 2023 Jul; 64(7):1049-1055. PubMed ID: 37024301
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of [
Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
[TBL] [Abstract][Full Text] [Related]
8. [
Zhang J; He Q; Jiang S; Li M; Xue H; Zhang D; Li S; Peng H; Liang J; Liu Z; Rao S; Wang J; Zhang R; Zhang L
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):937-950. PubMed ID: 36346437
[TBL] [Abstract][Full Text] [Related]
9. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
[TBL] [Abstract][Full Text] [Related]
10. Head-to-head comparison of
Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
[TBL] [Abstract][Full Text] [Related]
11. [
Yang L; Xu S; Cheng L; Gao C; Cao S; Chang Z; Wang K
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4051-4063. PubMed ID: 37542659
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast Activation Protein-Targeted PET/CT with
Xu W; Cai J; Peng T; Meng T; Pang Y; Sun L; Wu H; Zhang J; Chen X; Chen H
J Nucl Med; 2024 Jan; 65(1):40-51. PubMed ID: 37884330
[TBL] [Abstract][Full Text] [Related]
13. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
14. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using
Pang Y; Zhao L; Meng T; Xu W; Lin Q; Wu H; Zhang J; Chen X; Sun L; Chen H
J Nucl Med; 2023 Mar; 64(3):386-394. PubMed ID: 36215571
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography and computed tomography with [
Pang Y; Zhao L; Shang Q; Meng T; Zhao L; Feng L; Wang S; Guo P; Wu X; Lin Q; Wu H; Huang W; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1322-1337. PubMed ID: 34651226
[TBL] [Abstract][Full Text] [Related]
16. The potential utility of [
Lan L; Liu H; Wang Y; Deng J; Peng D; Feng Y; Wang L; Chen Y; Qiu L
Eur J Nucl Med Mol Imaging; 2022 Feb; 49(3):963-979. PubMed ID: 34410435
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of
Jiao M; Mingsong T; Hao J; Chunyin Z
Hell J Nucl Med; 2023; 26(2):123-131. PubMed ID: 37527048
[TBL] [Abstract][Full Text] [Related]
18. The added value of [
Liu Q; Shi S; Liu S; Xu X; Hu S; Zhang J; Wang C; Yu X; Song S
Eur Radiol; 2023 Jul; 33(7):5007-5016. PubMed ID: 36809431
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Baseline
Wu M; Wang Y; Yang Q; Wang X; Yang X; Xing H; Sang X; Li X; Zhao H; Huo L
J Nucl Med; 2023 Oct; 64(10):1532-1539. PubMed ID: 37500263
[TBL] [Abstract][Full Text] [Related]
20. Comparison of [
Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]